Amicus Therapeutics announces closing of underwritten offering of common stock
Amicus Therapeutics announced the closing of its previously announced offering of common stock. The Company issued a total of 19,354,839 shares in the offering at a price of $15.50 per share. Amicus granted underwriters a 30-day option to purchase up to an additional 2,903,225 shares. February 21, 2018